Blackstone Deploys Private Credit to Take Out Signant Loans

The Blackstone headquarters in New York.

Photographer: Michael Nagle/Bloomberg

Takeaways by Bloomberg AISubscribe

Blackstone Inc. is leading a private credit financing for life-sciences company Signant Health to replace more than $1 billion in bank-led leveraged loans, according to people familiar with the transaction.

The debt package for the digital product management provider for clinical trials will include a unitranche loan, a delayed-draw term loan and a revolving credit facility, said the people, who requested anonymity to discuss a private matter. The debt is being offered at 4.75 percentage points over the Secured Overnight Financing Rate, they said.

Subscribe now for uninterrupted access.
Get the context behind every story for $1.99/month.
Get uninterrupted access for just $1.99/month.
Cancel anytime.